Page 16 - Read Online
P. 16

Fearon et al. Metab Target Organ Damage 2022;2:13  https://dx.doi.org/10.20517/mtod.2022.12  Page 11 of 13

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2022.


               REFERENCES
               1.       Pournaras DJ, Photi ES, Barnett N, et al. Assessing the quality of primary care referrals to surgery of patients with diabetes in the East
                   of England: a multi-centre cross-sectional cohort study. Int J Clin Pract 2017;71:e12971.  DOI  PubMed
               2.       Meneghini LF. Perioperative management of diabetes: translating evidence into practice. Cleve Clin J Med 2009;76 Suppl 4:S53-9.
                   DOI  PubMed
               3.       Beckman JA, Creager MA. Vascular complications of diabetes. Circ Res 2016;118:1771-85.  DOI  PubMed
               4.       Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and
                   lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004;53:2079-86.  DOI  PubMed
               5.       Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care 2013;17:305.  DOI  PubMed  PMC
               6.       Finfer S, Chittock DR, Su SY, et al; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill
                   patients. N Engl J Med 2009;360:1283-97.  DOI  PubMed
               7.       Fabbri A, Marchesini G, Benazzi B, et al. Stress hyperglycemia and mortality in subjects with diabetes and sepsis. Crit Care Explor
                   2020;2:e0152.  DOI  PubMed  PMC
               8.       Roberts GW, Quinn SJ, Valentine N, et al. Relative hyperglycemia, a marker of critical Illness: introducing the stress hyperglycemia
                   ratio. J Clin Endocrinol Metab 2015;100:4490-7.  DOI  PubMed
               9.       International Diabetes Federation. IDF atlas, 10th edition 2021. Available from: https://www.diabetesatlas.org/ [Last accessed on 1 Sep
                   2022].
               10.      Dhatariya KK. Why the definitions used to diagnose diabetic ketoacidosis should be standardised. Diabetes Res Clin Pract
                   2018;135:227-8.  DOI  PubMed
               11.      Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a
                   report from the Surgical Care and Outcomes Assessment Program. Ann Surg 2013;257:8-14.  DOI  PubMed  PMC
               12.      Frisch A, Chandra P, Smiley D, et al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac
                   surgery. Diabetes Care 2010;33:1783-8.  DOI  PubMed  PMC
               13.      Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N
                   Engl J Med 2018;379:633-44.  DOI  PubMed
               14.      Centre for Perioperative Care. Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency
                   surgery, 2021. Available from: https://diabetes-resources-production.s3.eu-west-1.amazonaws.com/resources-s3/public/2021-
                   03/CPOC-Diabetes-Guideline2021.pdf [Last accessed on 1 Sep 2022].
               15.      Gillis C, Ljungqvist O, Carli F. Prehabilitation, enhanced recovery after surgery, or both? Br J Anaesth 2022;128:434-48.  DOI
               16.      Levy N, Dhatariya K. Pre-operative optimisation of the surgical patient with diagnosed and undiagnosed diabetes: a practical review.
                   Anaesthesia 2019;74 Suppl 1:58-66.  DOI  PubMed
               17.      Rollins KE, Varadhan KK, Dhatariya K, Lobo DN. Systematic review of the impact of HbA1c on outcomes following surgery in
                   patients with diabetes mellitus. Clin Nutr 2016;35:308-16.  DOI  PubMed
               18.      Wang J, Luo X, Jin X, et al. Effects of preoperative HbA1c levels on the postoperative outcomes of coronary artery disease surgical
                   treatment in patients with diabetes mellitus and nondiabetic patients: a systematic review and meta-analysis. J Diabetes Res
                   2020;2020:3547491.  DOI  PubMed  PMC
               19.      National Institute for Health and Care Excellence. Routine preoperative tests for elective surgery (NG45) 2016. Available from:
                   https://www.nice.org.uk/guidance/ng45 [Last accessed on 1 Sep 2022].
               20.      Garg R, Schuman B, Bader A, et al. Effect of preoperative diabetes management on glycemic control and clinical outcomes after
                   elective surgery. Ann Surg 2018;267:858-62.  DOI  PubMed
               21.      Juray S, Axen KV, Trasino SE. Remission of type 2 diabetes with very low-calorie diets-a narrative review. Nutrients 2021;13:2086.
                   DOI  PubMed  PMC
               22.      Kempf K, Röhling M, Banzer W, et al. High-Protein, Low-glycaemic meal replacement decreases fasting insulin and inflammation
                   markers-a 12-month subanalysis of the ACOORH trial. Nutrients 2021;13:1433.  DOI  PubMed  PMC
               23.      Pournaras DJ, Nygren J, Hagström-Toft E, Arner P, le Roux CW, Thorell A. Improved glucose metabolism after gastric bypass:
                   evolution of the paradigm. Surg Obes Relat Dis 2016;12:1457-65.  DOI  PubMed
               24.      Colles SL, Dixon JB, Marks P, Strauss BJ, O'Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes
                   in liver and abdominal fat by serial imaging. Am J Clin Nutr 2006;84:304-11.  DOI  PubMed
               25.      Ross LJ, Wallin S, Osland EJ, Memon MA. Commercial very low energy meal replacements for preoperative weight loss in obese
                   patients: a systematic review. Obes Surg 2016;26:1343-51.  DOI  PubMed
               26.      Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol
   11   12   13   14   15   16   17   18   19   20   21